Savient Gets Nod To Fund Ch. 11 Sale With Cash Collateral

Savient Gets Nod To Fund Ch. 11 Sale With Cash Collateral

A Delaware bankruptcy judge Wednesday gave Savient Pharmaceuticals Inc. the go-ahead to use cash collateral to fund its stay in Chapter 11, enabling the drug developer to proceed with a planned $55 million asset sale. ...read more

  • Tags: